Synthesis and Characterization of Novel Etodolac Transdermal Prodrugs

dc.contributor.advisorDr. Murad Abualhasan
dc.contributor.authorRonza Al Masaid
dc.contributor.authorLeen Atabeh
dc.contributor.authorShayma Smara
dc.date.accessioned2020-08-11T09:24:19Z
dc.date.available2020-08-11T09:24:19Z
dc.date.issued2019-05-30
dc.description.abstractEtodolac belongs to a class of drugs called non steroidal anti-inflammatory drugs (NSAIDs). These drugs are used for the management of mild to moderate pain, fever, and inflammation by reducing the levels of prostaglandins. The skin is a barrier to prevent drugs from entering the body especially polar ones, so for the topical formulation, lipid solubility of the drug is test taken into consideration when it is formulated for topical application. In this study we synthesized a group of etodolac prodrugs by increasing its lipophlicity through derivatization of etodolac by esterification with series of alkanoic acid. The study showed success of the synthesis of the aimed prodrugs. The synthesized drugs showed increased lipophilicity and the enhanced drug release when tested on mouse skin by Franz diffusion technique. Isopropyl etodolac prodrug showed the best features to be formulated as topical dermal ointment as it release was much improved compared with the parent drug.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.11888/15317
dc.language.isoenen_US
dc.titleSynthesis and Characterization of Novel Etodolac Transdermal Prodrugsen_US
dc.typeGraduation Projecten_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Synthesis and Characterization of Novel Etodolac Transdermal Prodrugs.pdf
Size:
10.33 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: